ClinicalTrials.Veeva

Menu

Diagnostic Value of D-dimer/Fibrinogen Ratio in Patients With Acute Aortic Dissection

R

Republic of Turkey Ministry of Health

Status

Enrolling

Conditions

Pulmonary Embolism
Aortic Dissection

Treatments

Diagnostic Test: D-dimer/fibrinogen ratio

Study type

Observational

Funder types

Other

Identifiers

NCT04251247
2020/514/169/B

Details and patient eligibility

About

Acute aortic dissection is rare but potentially life-threatening disease with an incidence of 5-30 cases per million, annually. Therefore prompt diagnosis is crucial. D-dimer values have been shown to be useful in the diagnosis of acute aortic dissection. Fibrinogen levels have been shown to be low, normal or high in individuals with acute aortic dissection. This study aims to investigate whether D-dimer/fibrinogen ratio can be valuable for diagnosis of acute aortic dissection.

Enrollment

159 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosis of acute aortic dissection
  • Diagnosis of acute pulmonary embolism
  • Diagnosis of non-cardiac chest pain

Exclusion criteria

  • Any etiology of chest pain other than acute aortic dissection, acute pulmonary embolism, or non-cardiac chest pain
  • Participants who do not give consent for enrollment

Trial design

159 participants in 3 patient groups

Acute aortic dissection
Description:
Patients with a diagnosis of acute aortic dissection.
Treatment:
Diagnostic Test: D-dimer/fibrinogen ratio
Acute pulmonary embolism
Description:
Patients with a diagnosis of acute pulmonary embolism
Treatment:
Diagnostic Test: D-dimer/fibrinogen ratio
Non-cardiac chest pain
Description:
Patients with non-cardiac chest pain
Treatment:
Diagnostic Test: D-dimer/fibrinogen ratio

Trial contacts and locations

2

Loading...

Central trial contact

Ahmet Can Topcu, M.D.; Avni Uygar Seyhan, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems